Leadership

Dr. Imbert is a seasoned biopharmaceutical leader who brings 25 years of technical manufacturing operations experience to Pliant. Most recently, Dr. Imbert served as Senior Vice President of CMC and Technical Operations at Chinook Therapeutics (acquired by Novartis). As a member of the Executive Committee, Dr. Imbert built and managed a fully outsourced CMC, manufacturing and supply chain organization in support of Chinook’s global Phase 1 to Phase 3 clinical trials and successfully led change management initiatives in support of assets transition into Novartis. Prior to Chinook, Dr. Imbert held the role of Senior Vice President of Pharmaceutical Sciences at Dermira (acquired by Eli Lily and Company). Over her 10-year tenure, she established fully virtual CMC, manufacturing and supply chain capabilities in a fit-for-purpose manner in support of a broad portfolio of small molecules and biologics to Phase 3 as well as the launch of QBREXZA^®. Prior to Dermira, Dr. Imbert held research and development leadership roles of increasing seniority at Anacor Pharmaceuticals (acquired by Pfizer), most recently serving as Vice President of Pharmaceutical Research and Development. Earlier in her career, Dr. Imbert held scientific and product development roles at Alza Corporation (a Johnson & Johnson company) and Cellegy Pharmaceuticals.

Dr. Imbert graduated with an engineering degree from Ecole Nationale Supérieure de Chimie de Paris (Chimie ParisTech) and received a Ph.D. in Pharmaceutical Sciences from the University of Cincinnati. Dr. Imbert was also a NIH Postdoctoral Scholar at the University of California San Francisco.